We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Medica Corporation

Medica markets and sells in vitro diagnostic analyzers, such as clinical chemistry analyzers, electrolyte analyzers, ... read more Featured Products: More products

Download Mobile App




Distribution Agreement Signed for Assistant Digital Cell Imaging System

By LabMedica International staff writers
Posted on 19 May 2014
Print article
Image: Medica EasyCell assistant (Photo courtesy of Medica Corporation).
Image: Medica EasyCell assistant (Photo courtesy of Medica Corporation).
HORIBA Medical (Montpellier, France) and Medica Corporation (Bedford, MA, USA) have entered into a nonexclusive agreement for the worldwide distribution of the EasyCell assistant digital hematology cell imaging system for use in hospitals and clinical laboratories worldwide.

The EasyCell assistant automatically locates white cells on a blood smear and preclassifies them on a display, grouped by cell type. The system displays images of red cells and platelets for performance of red cell morphology and platelet estimates. The EasyCell also features Remote Viewing Software for sharing of cell images throughout the hospital and Competency Review Software for training of medical technologists in the hematology laboratory.

Olivier Pou, corporate marketing director, HORIBA Medical commented on the agreement with the Medica Corp., "The EasyCell assistant is an important addition to our hematology product range and is a good match with our five-part differential hematology instrument portfolio. The addition of the Medica EasyCell assistant to our product offering makes it possible for HORIBA Medical to provide a complete range of advanced technology to our hematology customers, worldwide."

Medica Corp. uses its proprietary technology to manufacture easy-to-use, low-cost, blood testing analyzers. The analyzers are easy to operate and service and can be used routinely by personnel with a wide range of skill levels in hospital laboratories.

HORIBA Medical provides an extensive and complete line of hematology and clinical chemistry analyzers (including reagents) for in vitro medical diagnostics.

Related Links:

HORIBA Medical
Medica Corporation


New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Automated Blood Typing System
IH-500 NEXT
New
Automatic Biochemistry Analyzer
Audmax 180 Evolution
New
Nuclear Matrix Protein 22 Test
NMP22 Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.